NasdaqGS:BMRNBiotechs
BioMarin Balances VOXZOGO Canada Win With Debt Funded Amicus Expansion
BioMarin Pharmaceutical (NasdaqGS:BMRN) received a Notice of Compliance with Conditions from Health Canada for VOXZOGO, expanding access to its achondroplasia treatment in Canada.
The company is progressing a large notes offering intended to help fund its pending acquisition of Amicus Therapeutics.
These developments come as BioMarin shares trade at $59.94, with a 4.9% return over the past week and 8.6% over the past month.
For you as an investor, BioMarin sits at an interesting point. The...